Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial

Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.

(2020) Howard Safran et al.   JOURNAL OF CLINICAL ONCOLOGY

The benefit of taxane-based therapies over fluoropyrimidine plus platinum (FP) in the treatment of esophageal cancer: a meta-analysis of clinical studies

(2019) Tao Wang et al.   Drug Design Development and Therapy

Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial

(2018) B Sunde et al.   DISEASES OF THE ESOPHAGUS

Surrogate end-points for overall survival in 22 neoadjuvant trials of gastro-oesophageal cancers

(2017) Fausto Petrelli et al.   EUROPEAN JOURNAL OF CANCER

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma

(2017) Somnath Mukherjee et al.   EUROPEAN JOURNAL OF CANCER

Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer

(2015) Ta-Chen Huang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

(2015) Joel Shapiro et al.   LANCET ONCOLOGY

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer

(2013) J. A. Ajani et al.   ANNALS OF ONCOLOGY

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

(2012) P. van Hagen et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

(2011) Nobutoshi Ando et al.   ANNALS OF SURGICAL ONCOLOGY

Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer

(2011) David H. Ilson et al.   CANCER

S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophageal Adenocarcinoma

(2011) Lawrence P. Leichman et al.   JOURNAL OF CLINICAL ONCOLOGY

18F-FDG PET-Guided Salvage Neoadjuvant Radiochemotherapy of Adenocarcinoma of the Esophagogastric Junction: The MUNICON II Trial

(2011) C. Meyer zum Buschenfelde et al.   JOURNAL OF NUCLEAR MEDICINE

Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

(2008) Joel Tepper et al.   JOURNAL OF CLINICAL ONCOLOGY